ES2093124T3 - Procedimiento para la determinacion de la proteina total y de la presion oncotica de fluidos corporales que contienen proteinas. - Google Patents

Procedimiento para la determinacion de la proteina total y de la presion oncotica de fluidos corporales que contienen proteinas.

Info

Publication number
ES2093124T3
ES2093124T3 ES92103142T ES92103142T ES2093124T3 ES 2093124 T3 ES2093124 T3 ES 2093124T3 ES 92103142 T ES92103142 T ES 92103142T ES 92103142 T ES92103142 T ES 92103142T ES 2093124 T3 ES2093124 T3 ES 2093124T3
Authority
ES
Spain
Prior art keywords
procedure
determination
oncotic pressure
body fluids
total protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92103142T
Other languages
English (en)
Inventor
Hans-Dietrich Dr Polaschegg
Detlef Dr Westphal
Klaus Metzner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius SE and Co KGaA
Original Assignee
Fresenius SE and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius SE and Co KGaA filed Critical Fresenius SE and Co KGaA
Application granted granted Critical
Publication of ES2093124T3 publication Critical patent/ES2093124T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

2.1 LOS METODOS CONOCIDOS COMO P. EJ. FOTOMETRIA, TURBIDIMETRIA O TAMBIEN LA DETERMINACION DEL NITROGENO RESIDUAL SEGUN KJELDAHL SON RELATIVAMENTE COSTOSOS EN CUANTO A TIEMPO Y NO SON BIEN ADECUADOS PARA EL PROCEDIMIENTO DE CIRCULACION DE CAUDALES. 2.2 EL PROCEDIMIENTO DE LA INVENCION ES ESPECIALMENTE IDONEO PARA MEDICIONES EN EL PROCEDIMIENTO DE CIRCULACION DE CAUDALES, DONDE MEDIANTE LA DETERMINACION DEL VALOR DE CONDUCTIVIDAD Y DEL VALOR DE CONDUCTIVIDAD ELECTROLITICA DEL PLASMA DE LA SANGRE O SUERO SE OBTIENE LA CONCENTRACION TOTAL DE ALBUMINA Y A PARTIR DE ELLA SE CALCULA LA PRESION ONCOTICA.
ES92103142T 1991-03-09 1992-02-25 Procedimiento para la determinacion de la proteina total y de la presion oncotica de fluidos corporales que contienen proteinas. Expired - Lifetime ES2093124T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4107689A DE4107689A1 (de) 1991-03-09 1991-03-09 Verfahren und vorrichtung zur bestimmung des gesamteiweisses und des onkotischen druckes eiweisshaltiger koerperfluessigkeiten

Publications (1)

Publication Number Publication Date
ES2093124T3 true ES2093124T3 (es) 1996-12-16

Family

ID=6426940

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92103142T Expired - Lifetime ES2093124T3 (es) 1991-03-09 1992-02-25 Procedimiento para la determinacion de la proteina total y de la presion oncotica de fluidos corporales que contienen proteinas.

Country Status (3)

Country Link
EP (1) EP0503356B1 (es)
DE (2) DE4107689A1 (es)
ES (1) ES2093124T3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7569184B2 (en) 2002-04-23 2009-08-04 Home Access Health Corporation Quantitative analysis of a biological sample of unknown quantity
US7611670B2 (en) 2002-04-23 2009-11-03 Home Access Health Corporation Quantitative analysis of a biological sample of unknown quantity
CA2488933C (en) * 2002-04-23 2016-11-01 Home Access Health Corporation Quantitative analysis of a biological sample of unknown quantity
US9119577B2 (en) 2006-03-01 2015-09-01 Home Access Health Corporation Specimen collection device
NL2023197B9 (en) * 2019-05-24 2023-12-01 Cooperatie Avebe U A Diafiltration

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3627814A1 (de) * 1986-08-16 1988-02-25 Fresenius Ag Vorrichtung zur bestimmung des haematokrit
DE4025425A1 (de) * 1990-08-10 1992-02-13 Fresenius Ag Verfahren und vorrichtung zur bestimmung der konzentration von proteinen und des gesamteiweisses eiweisshaltiger koerperfluessigkeiten

Also Published As

Publication number Publication date
EP0503356A2 (de) 1992-09-16
DE59207443D1 (de) 1996-12-05
EP0503356B1 (de) 1996-10-30
EP0503356A3 (en) 1993-03-03
DE4107689A1 (de) 1992-09-10

Similar Documents

Publication Publication Date Title
ES2119411T5 (es) Combinaciones de proteinas y anticoagulantes tromboliticamente activos, y usos de los mismos.
ES2144179T3 (es) Inhibidores de adhesion ciclicos.
DE69842208D1 (de) Vorrichtung für eine isolierte Beckenperfusion
ATE113475T1 (de) Hybride prokoagulierende proteine.
ES2113532T3 (es) Dispositivo para la determinacion del nivel de llenado de un sistema circulatorio sanguineo.
ES2190820T3 (es) Procedimiento para el diagnostico precoz de carcinomas.
KR830005862A (ko) 인체 에리트로포에틴의 제조방법
ATE104348T1 (de) O-glycosyliertes ifn-alpha.
SE7601567L (sv) Polyhemoglobin
ATE273386T1 (de) Menschliches cyclin e
ATE250625T1 (de) IM WESENTLICHEN REINES ZONULIN ALS PHYSIOLOGISCHER MODULATOR VON ßTIGHT JUNCTIONSß BEI SÄUGERN
DE3372712D1 (en) A tube set intended for extracorporeal treatment of blood and similar perishable liquids
ATE135014T1 (de) Modifizierte proteine, modifizierte interferone alpha- und beta-phosphorylierte proteine, dna- sequenzen und analoge und deren verwendung
ES2093124T3 (es) Procedimiento para la determinacion de la proteina total y de la presion oncotica de fluidos corporales que contienen proteinas.
AU555699B2 (en) Pp13 protein from placenta
ES2151544T3 (es) Metodos para la deteccion y el tratamiento de individuos con celulas anormales que expresan antigenos peptidos hla-a2/tirosinasa.
ES2106096T3 (es) Procedimiento para asegurar glutation intracelular adecuado en el tejido.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
DE59409704D1 (de) In den menschlichen körper einführbares instrument
ES2054942T3 (es) Procedimiento para la determinacion de fructuosaminas.
DE3378979D1 (en) 1-acyl-3-pyridylmethylguanidines and their use as antihypertensive agents
DE3650368T2 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
DK0789583T3 (da) Fremgangsmåder og kits som anvender makrofagstimulerende protein
CO5070621A1 (es) Metodo para incrementar el volumen oseo
DK528386D0 (da) Proteinabsorptionsforaegende midler

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 503356

Country of ref document: ES